These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 2730708

  • 21. Glycoxidized HDL, HDL enriched with oxidized phospholipids and HDL from diabetic patients inhibit platelet function.
    Lê QH, El Alaoui M, Véricel E, Ségrestin B, Soulère L, Guichardant M, Lagarde M, Moulin P, Calzada C.
    J Clin Endocrinol Metab; 2015 May; 100(5):2006-14. PubMed ID: 25794249
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Low-density lipoproteins inhibit the Na+/H+ antiport in human platelets. A novel mechanism enhancing platelet activity in hypercholesterolemia.
    Nofer JR, Tepel M, Kehrel B, Wierwille S, Walter M, Seedorf U, Zidek W, Assmann G.
    Circulation; 1997 Mar 18; 95(6):1370-7. PubMed ID: 9118502
    [Abstract] [Full Text] [Related]

  • 24. Enhancement of platelet aggregation by low-density lipoproteins from IDDM patients.
    Watanabe J, Wohltmann HJ, Klein RL, Colwell JA, Lopes-Virella MF.
    Diabetes; 1988 Dec 18; 37(12):1652-7. PubMed ID: 3192039
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Modified forms of low density lipoprotein affect platelet aggregation in vitro.
    Aviram M.
    Thromb Res; 1989 Mar 15; 53(6):561-7. PubMed ID: 2734732
    [Abstract] [Full Text] [Related]

  • 27. Inhibitory effects of in vivo oxidized high-density lipoproteins on platelet aggregation: evidence from patients with abetalipoproteinemia.
    Calzada C, Véricel E, Colas R, Guillot N, El Khoury G, Drai J, Sassolas A, Peretti N, Ponsin G, Lagarde M, Moulin P.
    FASEB J; 2013 Jul 15; 27(7):2855-61. PubMed ID: 23507868
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The role of (E)-4-hydroxy-2-nonenal in platelet activation by low density lipoprotein and iron.
    Selley ML, Bartlett MR, Czeti AL, Ardlie NG.
    Atherosclerosis; 1998 Sep 15; 140(1):105-12. PubMed ID: 9733221
    [Abstract] [Full Text] [Related]

  • 32. [The effect of lipid peroxidation-modified lipoproteins on thrombocyte aggregation].
    Azizova OA, Vlasova II.
    Biull Eksp Biol Med; 1993 Nov 15; 116(11):485-7. PubMed ID: 8312535
    [Abstract] [Full Text] [Related]

  • 33. Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis.
    Holvoet P, Collen D.
    Atherosclerosis; 1998 Apr 15; 137 Suppl():S33-8. PubMed ID: 9694539
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. High density lipoprotein inhibits platelet 12-lipoxygenase activity.
    Fujimoto Y, Tsunomori M, Muta E, Yamamoto T, Nishida H, Sakuma S, Fujita T.
    Res Commun Mol Pathol Pharmacol; 1994 Sep 15; 85(3):355-8. PubMed ID: 7827811
    [Abstract] [Full Text] [Related]

  • 39. [Effect of low-density lipoprotein on enhanced microviscosity and aggregation of platelet].
    Chen SH.
    Zhonghua Yi Xue Za Zhi; 1987 May 15; 67(5):266-8. PubMed ID: 3115525
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.